ABSTRACT
The clinical implementation of a variable relative biological effectiveness (RBE) in proton therapy is currently controversially discussed. Initial clinical evidence indicates a variable proton RBE, which needs to be verified. In this study, a radiation response modelling framework for assessing clinical RBE variability is established. It was applied to four selected glioma patients (grade III) treated with adjuvant radio(chemo)therapy and who developed late morphological image changes on T1-weighted contrast-enhanced (T1w-CE) magnetic resonance (MR) images within approximately two years of recurrence-free follow-up. The image changes were correlated voxelwise with dose and linear energy transfer (LET) values using univariable and multivariable logistic regression analysis. The regression models were evaluated by the area-under-the-curve (AUC) method performing a leave-one-out cross validation. The tolerance dose TD50 at which 50% of patient voxels experienced toxicity was interpolated from the models. A Monte Carlo (MC) model was developed to simulate dose and LET distributions, which includes variance reduction (VR) techniques to decrease computation time. Its reliability and accuracy were evaluated based on dose calculations of the clinical treatment planning system (TPS) as well as absolute dose measurements performed in the patient specific quality assurance. Morphological image changes were related to a combination of dose and LET. The multivariable models revealed cross-validated AUC values of up to 0.88. The interpolated TD50 curves decreased with increasing LET indicating an increase in biological effectiveness. The MC model reliably predicted average TPS dose within the clinical target volume as well as absolute water phantom dose measurements within 2% accuracy using dedicated VR settings. The observed correlation of dose and LET with late brain tissue damage suggests considering RBE variability for predicting chronic radiation-induced brain toxicities. The MC model simulates radiation fields in patients precisely and time-efficiently. Hence, this study encourages and enables in-depth patient evaluation to assess the variability of clinical proton RBE.
Subject(s)
Monte Carlo Method , Proton Therapy , Relative Biological Effectiveness , Brain/radiation effects , Humans , Linear Energy Transfer , Phantoms, Imaging , Proton Therapy/adverse effects , Radiation Injuries/etiology , Radiotherapy Planning, Computer-Assisted , Reproducibility of ResultsSubject(s)
Brain Neoplasms/therapy , Brain/diagnostic imaging , Glioma/therapy , Models, Biological , Organs at Risk/diagnostic imaging , Proton Therapy , Adult , Biopsy , Brain/pathology , Brain/radiation effects , Brain Neoplasms/diagnostic imaging , Chemoradiotherapy, Adjuvant/methods , Dose Fractionation, Radiation , Follow-Up Studies , Glioma/diagnostic imaging , Humans , Magnetic Resonance Imaging , Middle Aged , Organs at Risk/pathology , Organs at Risk/radiation effects , Radiotherapy Planning, Computer-Assisted , Treatment Outcome , Tumor Burden/radiation effectsABSTRACT
There are investigated the concentration of thyroglobulin, thyroxine and triiodthyronine in serum of heart blood from autopsies. The level of hormones depends from the reason of death. In comparison with values of healthy living individuals the postmortem concentrations of Tg, TT4 and TT3 are very different. Highered values of Tg were observed in cases of accident death, who died some days after the injuries. Thyroxin was higher in cases of hanging and TT3 in cases of hanging and unexpected natural death.
Subject(s)
Cause of Death , Death, Sudden/pathology , Thyroglobulin/blood , Thyroxine/blood , Triiodothyronine/blood , Asphyxia/blood , Asphyxia/pathology , Humans , Wounds and Injuries/blood , Wounds and Injuries/pathologyABSTRACT
A data bank of forensic medicine is reported, which recreation is possible without any separate treatment. Informations available by computer-aided writing of autopsy-protocols are recorded automatically by a special programme. Coding is made by the SNOMED and METAS systems.